WENZHOU KANGNING HOSPITAL CO., LTD. Financials Wenzhou Kangning Hospital Co., Ltd.
Equities
2120
CNE100002383
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.3 HKD | +2.73% |
|
-3.25% | -16.30% |
| Apr. 03 | Wenzhou Kangning Posts 17% Rise in Inpatient Numbers | MT |
| Mar. 28 | Wenzhou Kangning Hospital Co., Ltd. Proposes Final Dividend for the Year Ended December 31, 2023 Payable on 28 June 2024 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,353 | 1,338 | 1,733 | 1,234 | 730.9 | 915.4 |
| Enterprise Value (EV) 1 | 2,390 | 1,652 | 2,172 | 1,851 | 1,405 | 1,649 |
| P/E ratio | 28.6 x | 23.8 x | 25 x | 29 x | -30.2 x | 10.7 x |
| Yield | 0.48% | - | - | - | - | 3.26% |
| Capitalization / Revenue | 3.15 x | 1.55 x | 1.68 x | 0.95 x | 0.49 x | 0.57 x |
| EV / Revenue | 3.2 x | 1.92 x | 2.11 x | 1.43 x | 0.95 x | 1.03 x |
| EV / EBITDA | 14.5 x | 17.2 x | 11.9 x | 11.1 x | 8.89 x | 8 x |
| EV / FCF | -37.5 x | -1,331 x | -38 x | -24.7 x | -20.8 x | 15.6 x |
| FCF Yield | -2.66% | -0.08% | -2.63% | -4.05% | -4.8% | 6.42% |
| Price to Book | 2.03 x | 1.15 x | 1.43 x | 1.06 x | 0.61 x | 0.71 x |
| Nbr of stocks (in thousands) | 75,500 | 73,040 | 72,140 | 72,140 | 74,600 | 74,600 |
| Reference price 2 | 31.17 | 18.32 | 24.03 | 17.11 | 9.798 | 12.27 |
| Announcement Date | 4/29/19 | 4/27/20 | 4/28/21 | 11/15/22 | 5/10/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 746 | 860.7 | 1,031 | 1,297 | 1,485 | 1,596 |
| EBITDA 1 | 165.3 | 96.21 | 182.5 | 166.7 | 158 | 206 |
| EBIT 1 | 127.6 | 51.98 | 129 | 105.7 | 83.1 | 135.1 |
| Operating Margin | 17.11% | 6.04% | 12.51% | 8.15% | 5.6% | 8.46% |
| Earnings before Tax (EBT) 1 | 106.9 | 55.52 | 87.9 | 95.7 | 15.6 | 99.18 |
| Net income 1 | 80.6 | 57.29 | 70 | 44.05 | -24.22 | 85.95 |
| Net margin | 10.8% | 6.66% | 6.79% | 3.4% | -1.63% | 5.38% |
| EPS 2 | 1.090 | 0.7700 | 0.9600 | 0.5900 | -0.3247 | 1.150 |
| Free Cash Flow 1 | -63.67 | -1.241 | -57.14 | -75.02 | -67.46 | 105.9 |
| FCF margin | -8.53% | -0.14% | -5.54% | -5.78% | -4.54% | 6.63% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 51.41% |
| FCF Conversion (Net income) | - | - | - | - | - | 123.21% |
| Dividend per Share 2 | 0.1500 | - | - | - | - | 0.4000 |
| Announcement Date | 4/29/19 | 4/27/20 | 4/28/21 | 11/15/22 | 5/10/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 36.2 | 314 | 439 | 616 | 674 | 734 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.219 x | 3.261 x | 2.403 x | 3.697 x | 4.263 x | 3.561 x |
| Free Cash Flow 1 | -63.7 | -1.24 | -57.1 | -75 | -67.5 | 106 |
| ROE (net income / shareholders' equity) | 6.47% | 3.1% | 4.58% | 3.3% | -0.84% | 6.36% |
| ROA (Net income/ Total Assets) | 4.52% | 1.64% | 3.69% | 2.91% | 2.07% | 2.97% |
| Assets 1 | 1,784 | 3,490 | 1,896 | 1,513 | -1,170 | 2,893 |
| Book Value Per Share 2 | 15.30 | 15.90 | 16.80 | 16.10 | 16.10 | 17.20 |
| Cash Flow per Share 2 | 2.560 | 2.410 | 2.860 | 2.530 | 3.630 | 5.690 |
| Capex 1 | 145 | 128 | 188 | 179 | 237 | 180 |
| Capex / Sales | 19.5% | 14.82% | 18.23% | 13.76% | 15.95% | 11.26% |
| Announcement Date | 4/29/19 | 4/27/20 | 4/28/21 | 11/15/22 | 5/10/23 | 4/26/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.30% | 103M | |
| -16.43% | 17.03B | |
| +5.41% | 12.61B | |
| +4.64% | 11.73B | |
| +2.48% | 10.17B | |
| +28.72% | 8.65B | |
| -2.68% | 7.81B | |
| +21.65% | 7.25B | |
| +5.12% | 6.66B | |
| +46.09% | 4.51B |
- Stock Market
- Equities
- 2120 Stock
- Financials Wenzhou Kangning Hospital Co., Ltd.